Algert Global’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65,235
Closed -$934K 1601
2024
Q1
$934K Sell
65,235
-15,290
-19% -$217K 0.04% 629
2023
Q4
$1.1M Sell
80,525
-41,075
-34% -$433K 0.04% 597
2023
Q3
$989K Sell
121,600
-27,579
-18% -$225K 0.05% 572
2023
Q2
$1.13M Buy
149,179
+16,965
+13% +$130K 0.05% 615
2023
Q1
$1.06M Buy
132,214
+6,274
+5% +$64.5K 0.05% 619
2022
Q4
$1.43M Buy
125,940
+27,491
+28% +$300K 0.08% 421
2022
Q3
$859K Buy
98,449
+22,165
+29% +$230K 0.05% 604
2022
Q2
$760K Buy
76,284
+8,382
+12% +$84.4K 0.06% 589
2022
Q1
$683K Buy
+67,902
New +$722K 0.04% 695

Other funds holding PTVE

Algert Global's PTVE Position: Q2 2024 in Review

Algert Global sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2024, closing a stake of 65,235 shares — an estimated $934K sold.

Algert Global first reported a position in PTVE in Q1 2022 and held it in 9 quarters. The position peaked at $1.43M in Q4 2022. 142 funds tracked by Wall St. Rank hold PTVE as of Q2 2024.

  • Algert Global reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2024 after selling out during the quarter.
  • Algert Global sold 65,235 Pactiv Evergreen Inc. Common stock shares in Q2 2024, an estimated $934K.
  • Algert Global first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and held it in 9 quarters.
  • Algert Global's Pactiv Evergreen Inc. Common stock position peaked at $1.43M in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2024.

Based on Algert Global's 13F filing for Q2 2024, filed 15 Aug 2024.